HK Stock Market Move | CHAOJU EYE CARE (02219) has risen by over 4%, intending to repurchase up to 50 million Hong Kong dollars of shares on the open market.

CHAOJU EYE CARE (02219) surged more than 4%, rising by 4.07% to HK$2.56 at the time of publication, with a turnover of HK$1.3851 million. On the news front, CHAOJU EYE CARE announced that on November 17, 2025, the board of directors had decided to authorize the repurchase of up to HK$50 million worth of company shares on the open market, in accordance with the share repurchase authorization approved by the company's shareholders at the annual general meeting held on June 6, 2025, and any subsequent updates or re-establishments approved by shareholders. The Company believes that repurchasing shares will demonstrate confidence in its business outlook and prospects, ultimately benefiting the Company and creating value for its shareholders. The board of directors may increase the maximum purchase amount under the share repurchase authorization from time to time depending on market conditions. If the board decides to increase the maximum repurchase amount, the Company will make a timely announcement in accordance with the listing rules as necessary.